ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Uniqure Nv

Uniqure Nv (0EE0)

31.50
0.00
(0.00%)
Closed January 29 10:30AM

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
31.50
Bid
0.00
Ask
0.00
Volume
427
0.00 Day's Range 0.00
31.50 52 Week Range 31.50
Market Cap
Previous Close
31.50
Open
-
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
12,613
Shares Outstanding
47,834,000
Dividend Yield
-
PE Ratio
-2.36
Earnings Per Share (EPS)
-6.45
Revenue
21.9M
Net Profit
-308.48M

About Uniqure Nv

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
Headquarters
Amsterdam, North Holland, Nld
Founded
-
Uniqure Nv is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker 0EE0. The last closing price for Uniqure Nv was US$31.50. Over the last year, Uniqure Nv shares have traded in a share price range of US$ 31.50 to US$ 31.50.

Uniqure Nv currently has 47,834,000 shares outstanding. The market capitalization of Uniqure Nv is US$1.51 billion. Uniqure Nv has a price to earnings ratio (PE ratio) of -2.36.

0EE0 Latest News

uniQure Announces Pricing of its Public Offering

uniQure Announces Pricing of its Public Offering LEXINGTON, Mass. and AMSTERDAM, Jan. 08, 2025 (GLOBE NEWSWIRE) -- uniQure N.V. (Nasdaq: QURE), a leading gene therapy company advancing...

uniQure Announces Proposed Public Offering

uniQure Announces Proposed Public Offering LEXINGTON, Mass. and AMSTERDAM, Jan. 07, 2025 (GLOBE NEWSWIRE) -- uniQure N.V. (Nasdaq: QURE), a leading gene therapy company advancing transformative...

uniQure Announces Alignment with FDA on Key Elements of Accelerated Approval Pathway for AMT-130 in Huntington’s Disease

uniQure Announces Alignment with FDA on Key Elements of Accelerated Approval Pathway for AMT-130 in Huntington’s Disease ~ U.S. Food and Drug Administration (FDA) agrees that data from ongoing...

uniQure Announces Dosing of First Patient in GenTLE Phase I/IIa Clinical Trial of AMT-260 for the Treatment of Refractory Mesial Temporal Lobe Epilepsy

uniQure Announces Dosing of First Patient in GenTLE Phase I/IIa Clinical Trial of AMT-260 for the Treatment of Refractory Mesial Temporal Lobe Epilepsy LEXINGTON, Mass. and AMSTERDAM, Nov. 21...

uniQure Announces Third Quarter 2024 Financial Results and Highlights Recent Company Progress

uniQure Announces Third Quarter 2024 Financial Results and Highlights Recent Company Progress ~ Type B meeting scheduled with the FDA in the fourth quarter of 2024 to initiate discussions...

uniQure Announces Dosing of First Patient in Phase I/II Clinical Trial of AMT-162 for the Treatment SOD1-ALS

uniQure Announces Dosing of First Patient in Phase I/II Clinical Trial of AMT-162 for the Treatment SOD1-ALS LEXINGTON, Mass. and AMSTERDAM, Oct. 15, 2024 (GLOBE NEWSWIRE) -- uniQure N.V...

uniQure Announces Orphan Drug Designation Granted to AMT-191 for the Treatment of Fabry Disease

uniQure Announces Orphan Drug Designation Granted to AMT-191 for the Treatment of Fabry Disease LEXINGTON, Mass. and AMSTERDAM, Sept. 23, 2024 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a...

uniQure Announces Dosing of First Patient in Phase I/IIa Clinical Trial of AMT-191 for the Treatment of Fabry Disease

uniQure Announces Dosing of First Patient in Phase I/IIa Clinical Trial of AMT-191 for the Treatment of Fabry Disease LEXINGTON, Mass. and AMSTERDAM, Aug. 15, 2024 (GLOBE NEWSWIRE) -- uniQure...

uniQure Announces Second Quarter 2024 Financial Results and Provides Company Update

uniQure Announces Second Quarter 2024 Financial Results and Provides Company Update ~ Announced RMAT designation for AMT-130 in Huntington’s disease and positive interim Phase I/II data...

uniQure Announces Closing of Sale of Manufacturing Facility to Genezen

uniQure Announces Closing of Sale of Manufacturing Facility to Genezen ~ uniQure maintains preferential access to industry-leading manufacturing capabilities to support its pipeline of gene...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10031.531.531.5194031.5DE
40031.531.531.5263531.5DE
120031.531.531.51261331.5DE
260031.531.531.5812831.5DE
520031.531.531.5887031.5DE
1560031.531.531.5329531.5DE
2600031.531.531.5208231.5DE

0EE0 - Frequently Asked Questions (FAQ)

What is the current Uniqure Nv share price?
The current share price of Uniqure Nv is US$ 31.50
How many Uniqure Nv shares are in issue?
Uniqure Nv has 47,834,000 shares in issue
What is the market cap of Uniqure Nv?
The market capitalisation of Uniqure Nv is USD 1.51B
What is the 1 year trading range for Uniqure Nv share price?
Uniqure Nv has traded in the range of US$ 31.50 to US$ 31.50 during the past year
What is the PE ratio of Uniqure Nv?
The price to earnings ratio of Uniqure Nv is -2.36
What is the cash to sales ratio of Uniqure Nv?
The cash to sales ratio of Uniqure Nv is 33.24
What is the reporting currency for Uniqure Nv?
Uniqure Nv reports financial results in USD
What is the latest annual turnover for Uniqure Nv?
The latest annual turnover of Uniqure Nv is USD 21.9M
What is the latest annual profit for Uniqure Nv?
The latest annual profit of Uniqure Nv is USD -308.48M
What is the registered address of Uniqure Nv?
The registered address for Uniqure Nv is PAASHEUVELWEG 25A, AMSTERDAM, NORTH HOLLAND, 1105 BP
What is the Uniqure Nv website address?
The website address for Uniqure Nv is www.uniqure.com
Which industry sector does Uniqure Nv operate in?
Uniqure Nv operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
MACMarechale Capital Plc
3.80p
(117.14%)
38.62M
DKEDukemount Capital Plc
0.045p
(42.86%)
905.37M
SCGLSealand Capital Galaxy Limited
8.00p
(37.93%)
13.92M
OBDOxford Biodynamics Plc
0.65p
(30.00%)
5.03M
BKYBerkeley Energia Limited
19.25p
(20.31%)
1.06M
NFXNuformix Plc
0.085p
(-41.38%)
262.46M
PPSProton Motor Power Systems Plc
0.225p
(-25.00%)
983.97k
VASTVast Resources Plc
0.115p
(-19.30%)
183.07M
GSCGs Chain Plc
1.30p
(-16.13%)
629k
SYMESupply@me Capital Plc
0.0026p
(-16.13%)
144.24M
DKEDukemount Capital Plc
0.045p
(42.86%)
905.37M
NTVONativo Resources Plc
0.0019p
(0.00%)
467.88M
INSPInspirit Energy Holdings Plc
0.0029p
(11.54%)
429.63M
MSMNMosman Oil And Gas Limited
0.025p
(-3.85%)
401.42M
TRPTower Resources Plc
0.0285p
(-3.39%)
303.27M

Discussion

View Full Feed
nwsun nwsun 3 minutes ago
You make sense. Others obviously rely on hopeful innocence. Wall St, where sociopaths are trained.
ADTX
bradford86 bradford86 3 minutes ago
how you like ackman pres?
FNMA
dipANDrip dipANDrip 3 minutes ago
Buy 0001/0002 lotto and wait. That is all 
DPLS
Zorax Zorax 4 minutes ago
Hasn't looked like human careful structure for a while now. AI can't tell the difference of that nuance of a compound sentence.
Howzitgoing Howzitgoing 5 minutes ago
Have you noticed ...?

Have you noticed Breathe is a respiratory medicine company exclusively licensed to use JadiCells. Or epilepsy bio, exclusively licensed to use jadicells in epilepsy? or ALS Biologics exclusively licensed to use jadicells in ALS. Those companies, controlled by TS
TSOI
Wrangler1 Wrangler1 6 minutes ago
5% of zero is zero. The TBI's ain't generating any revenue to speak of after being in biz for years. 
WDLF
TheSprinx TheSprinx 6 minutes ago
Good read. From Reddit:
https://www.reddit.com/r/HMBLblockchain/s/MA76wt6hlo


HMBL
Bubae Bubae 6 minutes ago
I have been looked back at the restricted share activity. Fortunately we have a board member who has been diligent in posting the outstanding share count updates. I have only been looking at this sine the beginning of January and have found these posts useful. Raadr had a huge balance of restricted
RDAR
TenKay TenKay 7 minutes ago
Meant 3(a)10…well known mechanism to get stock free trading by deceiving a judge as to the parties true intentions.
MULN
BDEZ BDEZ 7 minutes ago
Thanks for sharing...
Hosai Hosai 7 minutes ago
New post from Jesse (MayoMobile) on linkedin, already re-posted by Dr Missling - https://www.linkedin.com/feed/update/urn:li:activity:7290540574066065409/
AVXL
MasterBlastr MasterBlastr 9 minutes ago
You must be short too . . .
AMC
Stevekkk1 Stevekkk1 10 minutes ago
Information from AI:
There isn't a company specifically named "MIA Global" listed on any stock exchange.
ALYI
s404n1tn0cc s404n1tn0cc 11 minutes ago
Some say the Nickles that were thrown were just tokens. I suspect others having different interest will are going to give DJT issues.
May not make the End of 2025 IMO In a word "Greed"
DJT
Torez Torez 11 minutes ago
Yes, this company is a SCAM
NKLA
misterfishman misterfishman 12 minutes ago
Ohhhh this is going to be huge its well worth the wait.
IGPK
mick mick 14 minutes ago
1982 penny
https://youtu.be/8EYRAAGQJTk

https:// youtu.be/8EYRAAGQJTk
Jp_SHMP Jp_SHMP 15 minutes ago
New cryptocurrency 
Worldwide 

Woot woot 

They have cards in their sleeve 
Not telling us everything 

Ungry for cheap token 
IGPK

Your Recent History

Delayed Upgrade Clock